Medicine / D-0853-2026
U.S. Food and Drug AdministrationD-0853-2026
Dopamine HCl Inj., USP, 200 mg/5 mL (40 mg/mL), 5 mL Single-dose, 25 vials per tray, Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA, Vial…
Class II Distributed nationwide or U.S.-wide
Status: Ongoing
What was recalled
Dopamine HCl Inj., USP, 200 mg/5 mL (40 mg/mL), 5 mL Single-dose, 25 vials per tray, Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA, Vial NDC 0409-5820-11, Carton NDC 0409-5820-01.
Recalling firm
Pfizer
Reason for recall
Lack of Assurance of Sterility
Where it went
US Nationwide.
Shown as U.S. Food and Drug Administration published it (shortened where marked …). Recall Shelf does not change recall facts and is not affiliated with the agency.